Literature DB >> 3089590

Effects of recombinant human tumor necrosis factor alpha, recombinant human gamma-interferon, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony-stimulating factor, pluripoietin alpha, and recombinant erythropoietin in serum-free cultures.

L Lu, K Welte, J L Gabrilove, G Hangoc, E Bruno, R Hoffman, H E Broxmeyer.   

Abstract

The influences of pure human pluripotent colony-stimulating factor, highly purified pluripoietin alpha, pure recombinant human tumor necrosis factor alpha, pure recombinant human gamma-interferon, and natural prostaglandin E1 (PGE1) were evaluated on colony formation of multipotential and erythroid progenitor cells in the presence of recombinant erythropoietin and hemin and on colony formation of granulocyte-macrophage progenitors in normal human marrow cultured in the presence or absence of serum. Serum was replaced by bovine serum albumin, iron-saturated transferrin, cholesterol, and calcium chloride. Increasing concentrations of pluripotent colony-stimulating factor and pluripoietin alpha stimulated increasing numbers of colonies from nonadherent low-density T-lymphocyte-depleted cells in the absence and presence of serum. Growth was usually greater in the presence of serum and on a unit basis pluripoietin alpha was more active than pluripotent colony-stimulating factor. Recombinant human tumor necrosis factor alpha and recombinant human gamma-interferon suppressed colony formation colony forming unit-granulocyte-macrophage, burst forming unit-erythroid, and colony forming unit-granulocyte-erythroid-macrophage-megakaryocyte; PGE1 suppressed colony formation by colony-forming unit-granulocyte-macrophage, stimulated colony formation by burst forming unit-erythroid, and had no effects on colony formation by colony forming unit-granulocyte-erythroid-macrophage-megakaryocyte in both serum-containing and serum-free medium. The PGE1 enhancing effects on erythroid colony formation required T-lymphocytes. Thus, results are similar using serum-containing and serum-free cultures of human bone marrow cells and serum-free defined culture medium can be used to study the mechanism of action of purified natural and recombinant growth and suppressor molecules in vitro.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089590

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Effects of interleukin-2 and interleukin-2-activated cells on in vitro myelopoiesis.

Authors:  M Clerigue; P Pisa; L Tsai; M Hanson
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

2.  Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow.

Authors:  A Srivastava; L Lu
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

3.  Selective and indirect modulation of human multipotential and erythroid hematopoietic progenitor cell proliferation by recombinant human activin and inhibin.

Authors:  H E Broxmeyer; L Lu; S Cooper; R H Schwall; A J Mason; K Nikolics
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

4.  Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2b.

Authors:  M Freund; P von Wussow; J Knüver-Hopf; H Mohr; U Pohl; G Exeriede; H Link; H J Wilke; H Poliwoda
Journal:  Blut       Date:  1988-11

5.  Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors.

Authors:  J E Talmadge; O Bowersox; H Tribble; S H Lee; H M Shepard; D Liggitt
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

6.  Phase I study of recombinant human tumor necrosis factor alpha in advanced malignant disease.

Authors:  T Moritz; N Niederle; J Baumann; D May; E Kurschel; R Osieka; J Kempeni; E Schlick; C G Schmidt
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  Clonogenic growth of acute non-lymphocytic leukemia cells in serum-free medium.

Authors:  P A Bernabei; V Santini; O Dal Pozzo; R Bezzini; V Gattei; R Saccardi; G Rombolà; P R Ferrini
Journal:  Experientia       Date:  1988-10-15

8.  Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3',5'-cyclic monophosphate.

Authors:  A Pinto; D Aldinucci; V Gattei; V Zagonel; G Tortora; A Budillon; Y S Cho-Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

9.  Transferrin microheterogeneity in rheumatoid arthritis. Relation with disease activity and anemia of chronic disease.

Authors:  R A Feelders; G Vreugdenhil; G de Jong; A J Swaak; H G van Eijk
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

10.  Clonal growth of functionally normal and deficient neutrophils from the bone marrow of a patient with variant chronic granulomatous disease. Lack of reconstitution of oxidative burst defect by G-CSF, GM-CSF, and IFN-gamma in vitro.

Authors:  S Oez; J Birkmann; J R Kalden
Journal:  Ann Hematol       Date:  1993-01       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.